TCL Archive Letter to the Editors: Burzynski Responds To FDA Release Of Annual Report Data May 22, 1998
TCL Archive ASCO Highlights Seven of 4,000 Abstracts Submitted for Annual Meeting, June 3-7 May 27, 2011
TCL Archive Troubles of Two Landmark Cancer Drugs, Celebrex and Iressa, Likely to Shape cancer Prevention, FDA Policy. FDA Mulls Withdrawal of Iressa. January 7, 2005
